Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05725681 · ClinicalTrials.gov registry record · NA
Satiety of High-Protein Ramen Noodles
A NA study of Appetitive Behavior, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05725681: Completed NA study of Appetitive Behavior, sponsored by Texas Tech University.
NCT05725681 is a NA study of Appetitive Behavior that has completed, run by Texas Tech University. The registered enrollment target is 30 participants, below the 55-participant average among 11 other Appetitive Behavior trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05725681, a NA study of Appetitive Behavior, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine if high-protein instant ramen noodles acutely increase satiety, reduce hunger, and improve blood sugar levels compared to standard instant ramen noodles in generally healthy young to middle aged adults. In addition, investigators aim to test if intake of high-protein instant ramen noodles reduces caloric intake at the next meal compared to standard instant ramen noodles.
Primary Outcome
Calculated as satiety + fullness + (100 - hunger) + (100 - prospective food consumption)/4. Questions 1-4 from the Visual Analogue Scale will be used to assess satiety, fullness, hunger and prospective food consumption and calculate the Appetite Score
Conditions Studied
Interventions
- OTHER High protein ramen
- OTHER Standard ramen
Study Locations (1)
Texas
- Nutrition and Metabolic Health Initiative - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2023-12-02 |
| Phase | NA |
What the finished NCT05725681 record still lists
NCT05725681 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 55-participant average among 11 other Appetitive Behavior trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Appetitive Behavior appearing as the primary indexed condition, and to 2 interventions - of which High protein ramen is the first listed.
NCT05725681 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05725681 about?
NCT05725681 is a clinical study titled "Satiety of High-Protein Ramen Noodles". The aim of this study is to determine if high-protein instant ramen noodles acutely increase satiety, reduce hunger, and improve blood sugar levels compared to standard instant ramen noodles in generally healthy young to middle aged adults. In addition, investigators aim to test if intake of high-pr...
What is the current status of trial NCT05725681?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-06-01. Estimated completion is 2023-12-02.
What conditions does trial NCT05725681 study?
This clinical trial studies the following conditions: Appetitive Behavior.
What interventions are being tested in trial NCT05725681?
The interventions under investigation include: High protein ramen (OTHER), Standard ramen (OTHER).
Who is sponsoring clinical trial NCT05725681?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05725681 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Appetitive Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05725681's enrollment target sits among peer trials
30 8th of 11 higher than 4 of 11 other Appetitive Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Appetitive Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Food for Thought: Executive Functioning Around Eating Among Children
RECRUITING · NA
-
Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
-
SATISFY (geleSis100 Effects on AppeTIte Sensations, Feeding Behavior and Dietary energY)
COMPLETED · NA
-
Whole Grains, Gastric Emptying and Glycemic Response
COMPLETED · NA
-
Barley Beta-glucan, Glycemic Control, and Appetite
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI